Harvard Biotech Spinout Lands $10M to Make Platelets From Stem Cells – Xconomy
Xconomy |
Harvard Biotech Spinout Lands $10M to Make Platelets From Stem Cells
Xconomy Karlsson's startup aims to bring hospitals an alternative: platelets produced as needed from stem cells. Platelet BioGenesis, a spinout from Harvard University and Brigham and Women's Hospital, now has $10 million from a Series A round of funding to … |
